Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00517296 · ClinicalTrials.gov registry record · Phase 4
Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal Fistulas
A Phase 4 study of Crohn Disease and Rectal Fistula, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT00517296: Completed Phase 4 study of Crohn Disease and Rectal Fistula, sponsored by Vanderbilt University Medical Center.
NCT00517296 is a Phase 4 study of Crohn Disease and Rectal Fistula that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 21 participants, below the 205-participant average among 71 other Crohn Disease trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00517296, a Phase 4 study of Crohn Disease and Rectal Fistula, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to assess whether utilizing endoscopic ultrasound(EUS) to guide treatment can improve durable fistula healing in patients with Crohn's perianal fistulas and to get preliminary information regarding the effectiveness of Adalimumab for Crohn's perianal fistulas.
Primary Outcome
Complete cessation of fistula drainage at 48 weeks
Conditions Studied
Interventions
- PROCEDURE EUA with seton placement if necessary
- DRUG adalimumab
- PROCEDURE EUS
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2008-01 |
| Est. Completion | 2015-12 |
| Phase | Phase 4 |
What the finished NCT00517296 record still lists
NCT00517296 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 205-participant average among 71 other Crohn Disease trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Crohn Disease appearing as the primary indexed condition, and to 3 interventions - of which EUA with seton placement if necessary is the first listed.
NCT00517296 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00517296 about?
NCT00517296 is a clinical study titled "Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal Fistulas". This study is to assess whether utilizing endoscopic ultrasound(EUS) to guide treatment can improve durable fistula healing in patients with Crohn's perianal fistulas and to get preliminary information regarding the effectiveness of Adalimumab for Crohn's perianal fistulas.
What is the current status of trial NCT00517296?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2008-01. Estimated completion is 2015-12.
What conditions does trial NCT00517296 study?
This clinical trial studies the following conditions: Crohn Disease, Rectal Fistula.
What interventions are being tested in trial NCT00517296?
The interventions under investigation include: EUA with seton placement if necessary (PROCEDURE), adalimumab (DRUG), EUS (PROCEDURE).
Who is sponsoring clinical trial NCT00517296?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00517296 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Crohn Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00517296's enrollment target sits among peer trials
21 61st of 71 higher than 10 of 71 other Crohn Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Crohn Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
RECRUITING · Phase 4
-
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
RECRUITING · Phase 4
-
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
RECRUITING · Phase 4
-
Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial
ACTIVE NOT RECRUITING · Phase 4
-
Triple Combination Therapy in High Risk Crohn's Disease (CD)
COMPLETED · Phase 4
-
Flagyl Microbiome in Crohn's Disease
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia